These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28115355)

  • 21. Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan.
    Ghodousi A; Rizvi AH; Baloch AQ; Ghafoor A; Khanzada FM; Qadir M; Borroni E; Trovato A; Tahseen S; Cirillo DM
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting MmpL3 for anti-tuberculosis drug development.
    Bolla JR
    Biochem Soc Trans; 2020 Aug; 48(4):1463-1472. PubMed ID: 32662825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis.
    Chen C; Gardete S; Jansen RS; Shetty A; Dick T; Rhee KY; Dartois V
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463541
    [No Abstract]   [Full Text] [Related]  

  • 24. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
    J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis.
    Umare MD; Khedekar PB; Chikhale RV
    ChemMedChem; 2021 Oct; 16(20):3136-3148. PubMed ID: 34288519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MmpL3 a potential new target for development of novel anti-tuberculosis drugs.
    Rayasam GV
    Expert Opin Ther Targets; 2014 Mar; 18(3):247-56. PubMed ID: 24325728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
    Ismail N; Omar SV; Ismail NA; Peters RPH
    J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus.
    Nataraj V; Varela C; Javid A; Singh A; Besra GS; Bhatt A
    Mol Microbiol; 2015 Oct; 98(1):7-16. PubMed ID: 26135034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
    Gupta S; Cohen KA; Winglee K; Maiga M; Diarra B; Bishai WR
    Antimicrob Agents Chemother; 2014; 58(1):574-6. PubMed ID: 24126586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
    Viader-Salvadó JM; Garza-González E; Valdez-Leal R; del Bosque-Moncayo MA; Tijerina-Menchaca R; Guerrero-Olazarán M
    J Clin Microbiol; 2001 Jul; 39(7):2642-5. PubMed ID: 11427584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Kaushik A; Makkar N; Pandey P; Parrish N; Singh U; Lamichhane G
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6561-7. PubMed ID: 26259792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel MenA Inhibitors Are Bactericidal against
    Berube BJ; Russell D; Castro L; Choi SR; Narayanasamy P; Parish T
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962346
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane.
    Grzegorzewicz AE; Pham H; Gundi VA; Scherman MS; North EJ; Hess T; Jones V; Gruppo V; Born SE; Korduláková J; Chavadi SS; Morisseau C; Lenaerts AJ; Lee RE; McNeil MR; Jackson M
    Nat Chem Biol; 2012 Feb; 8(4):334-41. PubMed ID: 22344175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in
    Richard M; Gutiérrez AV; Viljoen A; Rodriguez-Rincon D; Roquet-Baneres F; Blaise M; Everall I; Parkhill J; Floto RA; Kremer L
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
    Pagliotto AD; Caleffi-Ferracioli KR; Lopes MA; Baldin VP; Leite CQ; Pavan FR; Scodro RB; Siqueira VL; Cardoso RF
    J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.
    Pule CM; Sampson SL; Warren RM; Black PA; van Helden PD; Victor TC; Louw GE
    J Antimicrob Chemother; 2016 Jan; 71(1):17-26. PubMed ID: 26472768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention.
    Nguyen TVA; Anthony RM; Bañuls AL; Nguyen TVA; Vu DH; Alffenaar JC
    Clin Infect Dis; 2018 May; 66(10):1625-1630. PubMed ID: 29126225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Koch M; Bugni TS; Sondossi M; Ireland CM; Barrows LR
    Planta Med; 2010 Oct; 76(15):1678-82. PubMed ID: 20506078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.